- $109.69m
- $487.04m
- $167.87m
- 70
- 78
- 52
- 74
Annual income statement for Invesque, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 217 | 196 | 198 | 193 | 168 |
Cost of Revenue | |||||
Gross Profit | 108 | 85 | 83.3 | 76.9 | 64.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 208 | 156 | 173 | 180 | 143 |
Operating Profit | 9.74 | 40.2 | 24.7 | 13.2 | 25.1 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -191 | -6.52 | -43.1 | -90.4 | -37.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -184 | -6.52 | -42 | -90.1 | -35.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -184 | -12.2 | -48.8 | -99.2 | -36.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -184 | -12.2 | -48.8 | -99.2 | -36.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.3 | -0.1 | -0.652 | -1.45 | -0.579 |